A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer.

about

Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode.Targeting NFκB signaling in GD2+ BCSCs.Alterations of Signaling Pathways Related to the Immune System in Breast Cancer: New Perspectives in Patient Management

P2860

Q41514200-C25A3390-1353-4382-B5A7-4015A20FE645 Q41669889-09DA8797-9A90-4864-B5BD-1059DC092832 Q57106000-22325766-C7B2-46D7-A668-0BBC68D5AE45

P2860

A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer.

Item

http://www.wikidata.org/entity/Q38788928

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A BRCA1 deficient, NFκB driven ...... triple negative breast cancer.

@en

type

Item

label

A BRCA1 deficient, NFκB driven ...... triple negative breast cancer.

@en

prefLabel

A BRCA1 deficient, NFκB driven ...... triple negative breast cancer.

@en

P1476

A BRCA1 deficient, NFκB driven ...... triple negative breast cancer.

@en

P2093

Gareth Irwin

http://www.w3.org/2001/XMLSchema#string

Niamh E Buckley

http://www.w3.org/2001/XMLSchema#string

Paul Mullan

http://www.w3.org/2001/XMLSchema#string

Paula Haddock

http://www.w3.org/2001/XMLSchema#string

Ricardo De Matos Simoes

http://www.w3.org/2001/XMLSchema#string

Richard Kennedy

http://www.w3.org/2001/XMLSchema#string

Stephen McQuaid

http://www.w3.org/2001/XMLSchema#string

P2860

BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene

Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

BRCA1 augments transcription by the NF-kappaB transcription factor by binding to the Rel domain of the p65/RelA subunit

Systematic identification of genomic markers of drug sensitivity in cancer cells

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

Regularization Paths for Generalized Linear Models via Coordinate Descent

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

P304

19884-19896

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.7865

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Frank Emmert-Streib

Eileen Parkes

P577

2016-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

297583616

http://www.w3.org/2001/XMLSchema#string

P698

26943587

http://www.w3.org/2001/XMLSchema#string

P932

4991425

http://www.w3.org/2001/XMLSchema#string

A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer.

about

P2860

P2860

A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932